Investors & Media
Press Releases
<u>Press</u> Releases
Select year:
Alcyone Therapeutics Strengthens Executive Team with New Senior Leadership Appointments
Alcyone Therapeutics Launches to Advance Next-Generation Gene Therapies for CNS Disorders with $23 Million in Funding Contribution from RTW Investments